A Single Arm, Phase II Open Label Trial to Investigate the Efficacy and Safety of Intra-dermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Nov 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Discoid lupus erythematosus
- Focus Therapeutic Use
- Acronyms TARGET-DLE
- 28 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Feb 2016 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 04 Feb 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2017 as reported by ClinicalTrials.gov record.